Patient | Preop biopsy histology (Gleason) and imaging for pelvic lymph nodes | Preop PSA (ng/mL) | Pathological tumour data described | Margin and pelvic lymph node dissection (PLND) status | Reference |
---|---|---|---|---|---|
1 (60 years old) | 3+4=7 CT negative | 8.87 | pT3a, 9% involvement of tumour, Gleason 4+3=7 | Margin negative PLND negative | 5 |
2 (70 years old) | 3+4=7 (no preop imaging) | 7.4 | pT3a, 36% involvement of tumour, Gleason 3+4=7 | Margin positive PLND negative | 5 |
3 (70 years old) | 4+5=9 CT negative | 14 | pT2c, 10% involvement of tumour, Gleason 4+5=9 | Margin negative PLND negative | 5 |
4 | 3+3=6 (no data on imaging) | 8.6 | 10% anterior prostate cancer bilaterally and 90% posterior | Margin negative PLND negative | 6 |
5 | 5+4=9 (no data on imaging) | 6.3 | Multifocal anterior and posterior | Margin positive anteriorly and at bladder neck PLND negative | 6 |
6 | 3+4=7 (no data on imaging) | 5.4 | Multifocal anterior and posterior | Margin positive left apex PLND not performed | 6 |
7 | 4+4=8 (no data on imaging) | 8.7 | Multifocal anterior and posterior | Margin positive posteriorly PLND positive | 6 |
8 | 4+4=8 (no data on imaging) | 5.0 | pT3a | PLND negative (no data on margin status) | 7 |
9 | 4+5=9 (no data on imaging) | 31.5 | pT3b | PLND positive (no data on margin status) | 7 |
10 | 4+4=8 (no data on imaging) | 6.1 | pT3b | PLND positive (no data on margin status) | 7 |
PSA, prostrate specific antigen.